Readmission rates and outcomes in adults with and without COVID-19 following inpatient chemotherapy admission: A nationwide analysis

Table 6 Independent predictors of 90 d readmission for inpatient chemotherapy, Nationwide Readmission Database, 2020

Variables	Hazard ratio	Confidence interval	P value
Age category
45-64 yr	0.84	0.80-0.89	< 0.001
65 yr and above	0.74	0.68-0.80	< 0.001
Discharge AMA	0.65	0.47-0.90	0.01
Payer type
Medicaid	1.02	0.95-1.09	0.633
Private insurance	1.02	0.95-1.08	0.631
Self pay	1.15	0.99-1.33	0.056
Median household income
25th-50th quintile	1.03	0.97-1.09	0.329
50th-75th quintile	1.04	0.98-1.11	0.166
> 75th quintile	1.03	0.96-1.10	0.471
COVID-19	0.88	0.66-1.18	0.396
Comorbidities
Congestive heart failure	0.93	0.85-1.01	0.086
Cardiac arrhythmias	0.97	0.92-1.02	0.198
Peripheral vascular disorders	1.15	1.04-1.26	0.004
Hypertension, uncomplicated	1.02	0.98-1.07	0.296
Paralysis	1.21	1.02-1.43	0.027
Chronic pulmonary disease	0.97	0.92-1.03	0.386
Diabetics, uncomplicated	0.92	0.87-0.99	0.01
Renal failure	0.91	0.83-0.99	0.046
Liver disease	0.89	0.82-0.98	0.017
HIV/AIDS	1.1	0.94-1.29	0.211
Lymphoma	1.14	1.09-1.20	< 0.001
Coagulopathy	0.95	0.90-1.00	0.093
Weight loss	0.93	0.88-0.99	0.019
Hypertension, complicated	1.03	0.93-1.14	0.604

AMA: Against medical advice; HIV/AIDS: Human immunodeficiency virus/acquired immuno-deficiency syndrome.